Weiss Asset Management’s Revance Therapeutics, Inc. RVNC Stock Holding History

Weiss Asset Management’s Portfolio RVNC Stock Details RVNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-65,400	Closed	-$199K	–	734
2024 Q4	$199K	Sell	65,400 -20,000	-23%	-$87.1K	﹤0.01%	570
2024 Q3	$443K	Buy	+85,400	New	+$424K	0.01%	519

Other funds holding RVNC

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Weiss Asset Management's RVNC Position: Q1 2025 in Review

Weiss Asset Management sold out of Revance Therapeutics, Inc. (RVNC) in Q1 2025, closing a stake of 65,400 shares — an estimated $199K sold.

Weiss Asset Management first reported a position in RVNC in Q3 2024 and held it in 2 quarters. The position peaked at $443K in Q3 2024. 1 fund tracked by Wall St. Rank holds RVNC as of Q1 2025.

Weiss Asset Management reported no remaining Revance Therapeutics, Inc. position as of Q1 2025 after selling out during the quarter.
Weiss Asset Management sold 65,400 Revance Therapeutics, Inc. shares in Q1 2025, an estimated $199K.
Weiss Asset Management first reported a position in Revance Therapeutics, Inc. in Q3 2024 and held it in 2 quarters.
Weiss Asset Management's Revance Therapeutics, Inc. position peaked at $443K in Q3 2024.
1 fund tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q1 2025.

Based on Weiss Asset Management's 13F filing for Q1 2025, filed 15 May 2025.